Search research articles
Contact Us
Filters
Showing results (11-20 of 54) with videos related to
Page
of 6
Sort By:
Pacing and Clinical Electrophysiology : PACE
|
April 12, 2003
Is the outcome of cardiac resynchronization therapy related to the underlying etiology?
Maurizio Gasparini, Massimo Mantica, Paola Galimberti, et al.
Giornale Italiano Di Cardiologia (2006)
|
June 17, 2010
[Gender differences of at risk patients with overt heart failure in the real world of general practice. Data from the GIPSI (Gestione Integrata Progetto Scompenso in Italia) registry]
Edoardo Gronda, Alberto Aronica, Marco Visconti, et al.
Pacing and Clinical Electrophysiology : PACE
|
February 17, 2007
Three years of cardiac resynchronization therapy: could superior benefits be obtained in patients with heart failure and narrow QRS?
Maurizio Gasparini, François Regoli, Paola Galimberti, et al.
Pacing and Clinical Electrophysiology : PACE
|
October 28, 2008
Insulin-treated type 2 diabetes is associated with a decreased survival in heart failure patients after cardiac resynchronization therapy
Maurizio Mangiavacchi, Maurizio Gasparini, Stefano Genovese, et al.
Vaccines
|
May 28, 2022
New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine
Emanuele Nappi, Maria De Santis, Giovanni Paoletti, et al.
Journal of the American College of Cardiology
|
August 15, 2006
Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation
Maurizio Gasparini, Angelo Auricchio, François Regoli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
June 4, 2020
Fulminant myocarditis triggered by OC43 subtype coronavirus: a disease deserving evidence-based care bundles
Giacomo Veronese, Manlio Cipriani, Maurizio Bottiroli, et al.
American Heart Journal
|
January 31, 2006
Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure
Maurizio Mangiavacchi, Maurizio Gasparini, Francesco Faletra, et al.
Reviews in Cardiovascular Medicine
|
March 1, 2022
Prognostic value of tricuspid regurgitation
Pier Pasquale Leone, Mauro Chiarito, Damiano Regazzoli, et al.
Reviews in Cardiovascular Medicine
|
July 30, 2024
Percutaneous Tricuspid Valve Repair
Antonio Mangieri, Alessandro Sticchi, Aisha Gohar, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 54) with videos related to
Sort By:
Page
of 6
Pacing and Clinical Electrophysiology : PACE
|
April 12, 2003
Is the outcome of cardiac resynchronization therapy related to the underlying etiology?
Maurizio Gasparini, Massimo Mantica, Paola Galimberti, et al.
Giornale Italiano Di Cardiologia (2006)
|
June 17, 2010
[Gender differences of at risk patients with overt heart failure in the real world of general practice. Data from the GIPSI (Gestione Integrata Progetto Scompenso in Italia) registry]
Edoardo Gronda, Alberto Aronica, Marco Visconti, et al.
Pacing and Clinical Electrophysiology : PACE
|
February 17, 2007
Three years of cardiac resynchronization therapy: could superior benefits be obtained in patients with heart failure and narrow QRS?
Maurizio Gasparini, François Regoli, Paola Galimberti, et al.
Pacing and Clinical Electrophysiology : PACE
|
October 28, 2008
Insulin-treated type 2 diabetes is associated with a decreased survival in heart failure patients after cardiac resynchronization therapy
Maurizio Mangiavacchi, Maurizio Gasparini, Stefano Genovese, et al.
Vaccines
|
May 28, 2022
New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine
Emanuele Nappi, Maria De Santis, Giovanni Paoletti, et al.
Journal of the American College of Cardiology
|
August 15, 2006
Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation
Maurizio Gasparini, Angelo Auricchio, François Regoli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
June 4, 2020
Fulminant myocarditis triggered by OC43 subtype coronavirus: a disease deserving evidence-based care bundles
Giacomo Veronese, Manlio Cipriani, Maurizio Bottiroli, et al.
American Heart Journal
|
January 31, 2006
Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure
Maurizio Mangiavacchi, Maurizio Gasparini, Francesco Faletra, et al.
Reviews in Cardiovascular Medicine
|
March 1, 2022
Prognostic value of tricuspid regurgitation
Pier Pasquale Leone, Mauro Chiarito, Damiano Regazzoli, et al.
Reviews in Cardiovascular Medicine
|
July 30, 2024
Percutaneous Tricuspid Valve Repair
Antonio Mangieri, Alessandro Sticchi, Aisha Gohar, et al.
Page
of 6